monoclonal antibody against canine monocytes/macrophages

2
SELECTION AND CLONING PROCEDURE 10 8 spleen immunized cells and 10 7 Sp2/O myeloma cells (Sp20-Ag14, mouse myeloma, lymphoblast suspension cell line) were fused between 1/10 ratio in the presence of poly- ethylene glycol (PEG 3700, Sigma Chemical Co.), following standard procedures. 2 After fusion, cells were distributed in ten 96-well tissue culture plates with RPMI supplemented with 100 IU mL 1 of penicillin, 100 g mL 1 of streptomycin, 2 mM L-glutamine, and 10% of heat-inactivated fetal calf serum sup- plemented with HAT (100 mM hypoxantine, 0.4 M aminopterine, and 16 M thymidine). After 14–21 days, hybrid cells showing antibody activity against canine leukocyte screened by cell ELISA, for the detection of antigens of fixed canine PBMC, were cultured further using a layer of feeder cells from a non-immunized Balb/c mouse to assist in the early stages of growth. The IH1 mAb was subjected to three subse- quent sub-cloning steps by limiting dilution. SPECIFIC ANTIGEN IDENTIFIED The specificity of this monoclonal antibody has been deter- mined by ELISA, indirect immunofluorescence, and immuno- histochemistry on canine PBMC and canine frozen tissue sec- tions of lymph node, spleen, liver, and skin as well as immunofluorescence on peripheral blood monocytes-derived macrophages and flow cytometry analyses. The results indi- cated that this monoclonal antibody specific for canine leuko- cytes did not react with epitopes on human and mouse leuko- cytes. HEAVY AND LIGHT CHAIN OF IMMUNOGLOBULIN MAb was identified as the IgG class, which were IgG1, using hybridoma subisotyping kit (Monoclonal Antibody-Based Mouse Ig Isotyping Kit, BD PharMingen, Los Angeles, CA) system. ANTIGEN USED FOR IMMUNIZATION Canine blood was collected by venipuncture of the cephalic vein into tubes containing enough heparin to produce a final concentration of 10 IU mL 1 . The peripheral blood mononu- clear cells (PBMC) were isolated by centrifugation of diluted blood at 1:2 HBSS (Hank’s balanced salt solution, Sigma Chemical Co., St. Louis, MO) layered on Histopaque 1077 (Sigma Chemical Co.). Cells were washed twice in HBSS. Mitogen-stimulated PBMC were obtained by incubating these cells at the concentration of 5 10 6 /mL, with 5 g/mL of con- canavalin A (ConA, Sigma Chemical Co.) in RPMI 1640 (Sigma Chemical Co.) supplemented with 100 IU mL 1 of peni- cillin, 100 g mL 1 of streptomycin, 2 mM L-glutamine, and 20% of heat-inactivated fetal calf serum (GIBCO, Gaithersburg, MD) for 48 h in a 100% humidified atmosphere containing 5% CO 2 at 37°C. Stimulated or non-stimulated cells were adjusted to a total of 10 7 cells, sonicated, and emulsified in an equal vol- ume of complete or incomplete Freund’s adjuvant (Sigma Chemical Co.). METHOD OF IMMUNIZATION Two groups of five 8-week-old BALB/c mice were immunized with antigen from ConA-stimulated or with non-stimulated ca- nine PBMC with complete Freund’s adjuvant. The immuniza- tion consisted of one intraperitoneal followed by two subcuta- neous injections (totaling 10 7 cells per animal in 200 L). Two identical boosters were given 2 and 4 weeks after the first im- munization, using the same amount of cells, emulsified in in- complete Freund’s adjuvant. Two weeks after the second booster, the mice were tested for the presence of circulating an- tibody against canine PBMC by indirect enzyme-linked im- munosorbent assay (ELISA). 1 The animal with the highest an- tibody titer was injected intravenously with 10 7 sonicated canine PBMC in 200 L of phophate-buffered saline (PBS), 0.15 M, pH 7.2. Three days later, the animal was sacrificed and a single-cell splenocyte suspension was obtained for fusion. 326 HYBRIDOMA AND HYBRIDOMICS Volume 23, Number 5, 2004 © Mary Ann Liebert, Inc. Monoclonal Antibody Against Canine Monocytes/Macrophages Monoclonal Antibodies

Upload: leduong

Post on 09-Apr-2017

213 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Monoclonal Antibody Against Canine Monocytes/Macrophages

SELECTION AND CLONING PROCEDURE

108 spleen immunized cells and 107 Sp2/O myeloma cells(Sp20-Ag14, mouse myeloma, lymphoblast suspension cellline) were fused between 1/10 ratio in the presence of poly-ethylene glycol (PEG 3700, Sigma Chemical Co.), followingstandard procedures.2 After fusion, cells were distributed in ten96-well tissue culture plates with RPMI supplemented with 100IU mL�1 of penicillin, 100 �g mL�1 of streptomycin, 2 mML-glutamine, and 10% of heat-inactivated fetal calf serum sup-plemented with HAT (100 mM hypoxantine, 0.4 �Maminopterine, and 16 �M thymidine). After 14–21 days, hybridcells showing antibody activity against canine leukocytescreened by cell ELISA, for the detection of antigens of fixedcanine PBMC, were cultured further using a layer of feedercells from a non-immunized Balb/c mouse to assist in the earlystages of growth. The IH1 mAb was subjected to three subse-quent sub-cloning steps by limiting dilution.

SPECIFIC ANTIGEN IDENTIFIED

The specificity of this monoclonal antibody has been deter-mined by ELISA, indirect immunofluorescence, and immuno-histochemistry on canine PBMC and canine frozen tissue sec-tions of lymph node, spleen, liver, and skin as well asimmunofluorescence on peripheral blood monocytes-derivedmacrophages and flow cytometry analyses. The results indi-cated that this monoclonal antibody specific for canine leuko-cytes did not react with epitopes on human and mouse leuko-cytes.

HEAVY AND LIGHT CHAIN OFIMMUNOGLOBULIN

MAb was identified as the IgG class, which were IgG1, usinghybridoma subisotyping kit (Monoclonal Antibody-BasedMouse Ig Isotyping Kit, BD PharMingen, Los Angeles, CA)system.

ANTIGEN USED FOR IMMUNIZATION

Canine blood was collected by venipuncture of the cephalicvein into tubes containing enough heparin to produce a finalconcentration of 10 IU mL�1. The peripheral blood mononu-clear cells (PBMC) were isolated by centrifugation of dilutedblood at 1:2 HBSS (Hank’s balanced salt solution, SigmaChemical Co., St. Louis, MO) layered on Histopaque 1077(Sigma Chemical Co.). Cells were washed twice in HBSS. Mitogen-stimulated PBMC were obtained by incubating thesecells at the concentration of 5 � 106/mL, with 5 �g/mL of con-canavalin A (ConA, Sigma Chemical Co.) in RPMI 1640(Sigma Chemical Co.) supplemented with 100 IU mL�1 of peni-cillin, 100 �g mL�1 of streptomycin, 2 mM L-glutamine, and20% of heat-inactivated fetal calf serum (GIBCO, Gaithersburg,MD) for 48 h in a 100% humidified atmosphere containing 5%CO2 at 37°C. Stimulated or non-stimulated cells were adjustedto a total of 107 cells, sonicated, and emulsified in an equal vol-ume of complete or incomplete Freund’s adjuvant (SigmaChemical Co.).

METHOD OF IMMUNIZATION

Two groups of five 8-week-old BALB/c mice were immunizedwith antigen from ConA-stimulated or with non-stimulated ca-nine PBMC with complete Freund’s adjuvant. The immuniza-tion consisted of one intraperitoneal followed by two subcuta-neous injections (totaling 107 cells per animal in 200 �L). Twoidentical boosters were given 2 and 4 weeks after the first im-munization, using the same amount of cells, emulsified in in-complete Freund’s adjuvant. Two weeks after the secondbooster, the mice were tested for the presence of circulating an-tibody against canine PBMC by indirect enzyme-linked im-munosorbent assay (ELISA).1 The animal with the highest an-tibody titer was injected intravenously with 107 sonicatedcanine PBMC in 200 �L of phophate-buffered saline (PBS),0.15 M, pH 7.2. Three days later, the animal was sacrificed anda single-cell splenocyte suspension was obtained for fusion.

326

HYBRIDOMA AND HYBRIDOMICSVolume 23, Number 5, 2004© Mary Ann Liebert, Inc.

Monoclonal Antibody Against CanineMonocytes/Macrophages

Monoclonal Antibodies

Page 2: Monoclonal Antibody Against Canine Monocytes/Macrophages

327

MONOCLONAL ANTIBODIES327

AVAILABILITY

Tissue culture supernatant Yes ✓ NoAscitic fluid Yes ✓ NoHybridoma cells Yes No ✓

ADDRESS CORRESPONDENCE TO:

Dr. Paulo Henrique Palis AguiarLaboratório de Patologia e Bio-Intervenção (LPBI)Gonçalo Moniz Research Center (CPqGM)Oswaldo Cruz Foundation (FIOCRUZ)Av. Valdemar Falcão n. 121Brotas, Salvador, BahiaBrazil 40295-001E-mail: [email protected]

orDr. Lain Carlos Pontes-de CarvalhoLaboratório de Patologia e Bio-Intervenção (LPBI)

Gonçalo Moniz Research Center (CPqGM)Oswaldo Cruz Foundation (FIOCRUZ)Av. Valdemar Falcão n. 121Brotas, Salvador, BahiaBrazil 40295-001E-mail: [email protected]

REFERENCES

1. Baumgarten H: A cell ELISA for the quantitation of leuko-cyte antigens. J Immunol Methods 1989;94:91–98.

2. Harlow E, and Lane D: Antibodies: A Laboratory Manual.Cold Spring Harbor Laboratory Press, Cold Spring Harbor,NY, 1988.

3. Cobbold S, and Metcalf S: Monoclonal antibodies that de-fine canine homologues of human CD antigens. Summaryof the First International Canine Leukocyte Antigen Work-shop (CLAW). Tissue Antigens 1994;43:137–154.